Axsome Therapeutics Inc

Manager, Quality Assurance – GxP (GVP)

Ireland

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Position Overview

  • Location Type: [Not Specified]
  • Employment Type: Full Time
  • Job Type: Management

Job Description Summary: The Manager, Quality Assurance – GxP (GVP) is responsible for managing GxP Quality Assurance (QA) functions with an emphasis on Good Pharmacovigilance Practice (GVP) compliance for pre- and post-marketed products. The incumbent is responsible for QA oversight and support of pharmacovigilance function. This involves engaging and collaborating with cross-functional internal and external teams to evaluate processes, procedures, and activities for adherence to relevant industry standards, regulatory guidelines, and company Standard Operating Procedures (SOPs) as appropriate. They will assist in inspection readiness activities. The incumbent will support and/or conduct internal and external/vendor GVP audits of pharmacovigilance processes, safety vendors, distributors, market research vendors, patient support programs, etc. The Manager, Quality Assurance – GxP (GVP) supports adherence to relevant regulatory requirements and company Standard Operating Procedures (SOPs) as appropriate.

Responsibilities

  • Partners with Pharmacovigilance function to ensure GVP compliance.
  • Assists in identifying and communicating pharmacovigilance-related risks and opportunities for process improvement.
  • Performs internal and external audits as assigned to assure compliance with GVP regulations and guidelines.
  • Communicates audit results to internal stakeholders and writes audit reports.
  • Assesses audit responses and ensures closure of corrective action preventative actions (CAPAs).
  • Participates in regulatory authority inspections and assists with GxP inspection readiness activities.
  • Maintains effective relationships with colleagues and other departments by working collaboratively to deliver high quality service to the organization.
  • Ensures appropriate and timely escalation of quality issues, including issues of significant deviations to QA Management and makes appropriate recommendations for correction and improvement as may be necessary.
  • Engages in quality system continuous improvement initiatives to enforce the quality culture.
  • Performs other tasks and assignments as needed and specified by management.

Qualifications

  • Bachelor’s degree in a scientific discipline.
  • Minimum of 6 years of relevant experience in Quality Assurance or related role in a pharmaceutical, biotechnology, or related environment.
  • Knowledge and understanding of global GVP regulations, predominantly EMA and FDA.
  • Experience leading and/or conducting QA audits.
  • Demonstrated ability to develop and foster positive, collaborative relationships with internal staff as well as with external, third-party vendors.
  • Proficiency with Microsoft Office.
  • Excellent verbal and written communication skills.
  • Ability to work independently and collaboratively, as required, in a fast-paced, matrixed, team environment consisting of internal and external team members.
  • Analytical thinker with excellent problem-solving skills and the ability to adapt.

Salary:

  • [Not Specified]

Additional Information:

  • [Not Specified]

Skills

GxP
GVP
Pharmacovigilance
Audit
Regulatory Compliance
CAPA
Inspection Readiness
Process Improvement
Cross-functional Collaboration

Axsome Therapeutics Inc

Develops therapies for CNS disorders

About Axsome Therapeutics Inc

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

New York City, New YorkHeadquarters
2012Year Founded
$430.7MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Performance Bonus
Company Equity

Risks

Increased competition from companies like Compass Pathways in the CNS market.
Potential delays in AXS-07 launch amid growing market anticipation.
Departure of key personnel like Lori Englebert may impact strategic direction.

Differentiation

Axsome focuses on CNS disorders with limited current treatment options.
AXS-05, an NMDA receptor antagonist, targets major depressive disorder and treatment-resistant depression.
Axsome's balanced portfolio includes both clinical and research stage products.

Upsides

FDA's fast-tracking of CNS treatments could expedite Axsome's drug approvals.
Increased investment in CNS R&D drives innovation, benefiting Axsome's pipeline.
Growing personalized medicine trend offers Axsome opportunities for tailored therapies.

Land your dream remote job 3x faster with AI